SAN DIEGO, Sept. 4, 2018 /PRNewswire/ — NuVasive, Inc. (NASDAQ : NUVA ), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company will showcase industry-leading solutions for creating better clinical outcomes for spine procedures at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum being held September 6-8, 2018, in Las Vegas at Caesars Palace.
During SMISS 2018, NuVasive will feature its Lateral Single-Position Surgery procedure benefits, which may include reducing the number of times a patient has to be repositioned for greater operating room (OR) efficiency, along with the other benefits of minimally invasive spine surgery. Attendees will hear directly from leading surgeons of the procedure and learn what NuVasive is doing to incorporate advanced materials into its surgical implants. Attendees will also hear more about the Surgical IntelligenceTM ecosystem which incorporates the LessRay® technology to proactively combat radiation exposure in the OR. LessRay offers the surgeon and hospital system the opportunity to use significantly reduced radiation imaging in the OR, while providing image stitching for surgeons to quickly combine together fluoroscopic images of any spine segment.
In addition, the NuVasive industry lunch session, Leading. Expanding. Advancing. Insights to Lateral Procedural Solutions and Technology, by Adam Kanter, M.D., neurosurgeon at University of Pittsburgh Medical Center, will take place on Friday, September 7 from 12:50-1:10 p.m. PT in Roman Ballroom Exhibit Hall. 
“As a leader in minimally invasive spine surgery, NuVasive views SMISS as a dedicated industry meeting with a shared mindset that provides a valuable forum where we can partner with surgeons to advance learnings of new technologies and procedures,” said Matt Link, executive vice president, strategy, technology and corporate development for NuVasive. “Specifically, we will show safer, faster and smarter surgery through Surgical Intelligence, our leadership position in Lateral Single-Position Surgery and the benefits our comprehensive procedural solutions offer to surgeons, patients and hospital systems.”
Conference attendees can visit NuVasive Booth #309 to experience the latest innovative spine solutions and systems firsthand from the NuVasive team of experts.
About NuVasive
NuVasive, Inc. (NASDAQ : NUVA ) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company’s portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With over $1 billion in revenues, NuVasive has an approximate 2,400 person workforce in more than 40 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA® platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
SOURCE NuVasive, Inc.